Key Transaction Details and Update
The disclosure is a follow-up to the company's intimation dated March 14, 2026. The Board of Directors had previously approved (i) the execution of a Shareholder's Agreement between the Company, its wholly-owned subsidiary Nippon Life India AIF Management Limited (NAIF), and DWS Group GmbH & Co. KGaA (DWS), and (ii) noted a Share Subscription Agreement between NAIF and DWS. The transaction involves the proposed subscription by DWS and the subsequent issuance and allotment of equity shares of NAIF to DWS.
The Competition Commission of India (CCI) has granted its approval for this transaction. The approval was communicated via a letter dated June 30, 2026, which is enclosed with this filing. The CCI's approval reference is Registration No. C-2026/05/1420.
The company states that other appropriate approvals required for the transaction are currently in process or are awaited.
Regulatory References and Filings
The CCI's approval was granted under Section 31(1) of the Competition Act, 2002. The initial notice for the combination was filed by DWS on May 11, 2026, under sub-section (2) of Section 6 of the Act.
Document and Signatory Details
The letter is dated July 1, 2026, and is digitally signed by Valde Varghese Ponthokken, Company Secretary & Compliance Officer of Nippon Life India Asset Management Limited.
The company's correspondence address is 30th Floor, One Lodha Place, Senapati Bapat Marg, Lower Parel, Mumbai - 400013, Maharashtra. Its CIN is L65910MH1995PLC220793.
#Tags #NipponLifeIndiaAMC #CCI #SEBIDisclosure #RegulatoryCompliance #M&A